TAPE/#

Speaker

Comments

TAPE 86, A

005

Chair Ringo

Calls meeting to order at 3:05 p.m. Makes opening remarks regarding HB 2025 A. Makes opening remarks regarding SB 542, SB 740 and SB 659. Asks Committee Administrator to give overview of amendments for SB 542, SB 740 and SB 659. Welcomes Sen. Shields.

021

Matt Shields

Committee Administrator. Submits and gives overview of the -2 amendments for SB 740 (EXHIBIT A).

031

Chair Ringo

Asks if the -2 amendments have a referral to Ways and Means.

032

Shields

Replies that SB 740 has a subsequent referral to Ways and Means and the -2 amendments do not change that.

033

Shields

Submits and gives overview of the -1 amendments for SB 542 (EXHIBIT B). States that the -1 amendments eliminate the need for the Ways and Means referral and explains why. Believes the intention is to send SB 542 to the floor if the -1 amendments are adopted.

044

Shields

Submits and gives overview of -1 amendments for SB 659 (EXHIBIT C). Explains that the -1 amendments replace the original bill. States that SB 659 contains a blank and the intent is to pass SB 659 to Ways and Means to decide the expenditure limitation.

052

Chair Ringo

Asks committee if they have any questions on these bills.

053

Sen. Beyer

Replies no.

055

Chair Ringo

Opens public hearing on HB 2025 A.

HB 2025 A – PUBLIC HEARING

063

Rep. Bob Jensen

Represents House District 58. Discusses hearing on HB 2025 A in the House Water Committee. Believes HB 2025 A is one of the most important health bills that will be heard this session.

081

Rep. Gordon Anderson

Represents House District 3. States that he is also testifying as a dentist. States that HB 2025 A is a good deal for the people of Oregon and in particular children. Discusses dental care for children. States that the water supply is the most likely source for protection. Discusses safety of fluoride. Urges committee to pass HB 2025 A to the floor. Relates anecdote.

140

Rep. Mitch Greenlick

Represents House District 33. States that he is also testifying as a Public Health Scientist. Discusses safety of fluoride. Discusses oral health. Urges committee to pass HB 2025 A and thanks committee for holding a hearing.

180

Chair Ringo

Says that he has never studied this issue until recently. Reads an email from a dentist in Lake Oswego who opposes fluoridation of water. Believes that it is not as simple as witnesses have made it seem. Appreciates witness’ testimony.

195

Sen. Shields

Says that he also gets a lot of emails and is frustrated by the competing sciences. States concern for the lack of involvement of the Food and Drug Administration (FDA) over the last 50 years.

203

Rep. Greenlick

States that fluoride is not a medication just as chlorine is not a medication to water. Discusses the FDA. Discusses cautionary rule. Discusses studies done.

228

Chair Ringo

Wants to hear from the invited testimony.

238

Jane Myers

Director of Government Affairs, Oregon Dental Association and Coordinator of Healthy Smiles Coalition. States support for HB 2025 A. Introduces proponents of HB 2025 A. Submits informational packet (EXHIBIT D) and webpage from the Center for Disease Control (CDC) (EXHIBIT E).

294

Kurt Ferre, DDS

General Dentist, Portland and Oregon Dental Association. Testifies in support of HB 2025 A. Discusses dental cavities. Discusses costs of oral health care. Discusses the Smile Survey done by the Department of Human Services (DHS) in 2002. Shares statistics provided by Dr. Kyle House, a pediatric dentist who treats children in Hood River which is not fluoridated and also in The Dalles which is fluoridated. Asks committee to move HB 2025 A to the Senate floor with a do pass recommendation.

358

Chair Ringo

Mentions a report published by the American Dental Association Journal in 2000 that says that the benefits of fluoride are topical and not systemic.

365

Ferre

Says that study was authored by Dr. John Featherstone from the University of California in San Francisco. Discusses study done.

377

Chair Ringo

Points out that the study indicates that substantial new information has been received in the last five years on how the benefits of fluoride accrue to people. Says that increases the level of uncertainty.

391

Ferre

States that this is not a dramatic shift. Discusses benefits of water fluoridation.

411

Michael Meredith, Ph.D.

Professor of Biochemistry, Department of Integrative Biosciences, Oregon Health and Science University. Discusses benefits of fluoridation.

TAPE 87, A

004

Meredith

Continues discussion on benefits of fluoridation. States that the topical effect of fluoride dates back to the late 1940s.

014

Chair Ringo

States that the topical effects appeared to be big news and that is why he raised the point.

015

Meredith

Explains what was said in the mentioned study.

019

Meredith

Mentions sodium fluoride. Discusses fluorosilicic acid compound. Discusses contaminants present in fluorosilicic acid. Discusses specifically lead and arsenic.

102

Chair Ringo

Asks about using sodium fluoride instead of fluorosilicic acid.

105

Meredith

Discusses use of sodium fluoride.

115

Chair Ringo

Verifies that witness believes that using sodium fluoride would increase the cost somewhat but the benefits would be negligible.

117

Meredith

Replies yes. Explains that the cost depends on the water district.

120

Chair Ringo

Says that he has received emails from people who have special health difficulties such as thyroid or liver problems. Asks if fluoride has ill effects for people with special health problems.

126

Ferre

Verifies that he mentioned thyroid.

127

Chair Ringo

Replies yes.

128

Ferre

Discusses impact of fluoride on the thyroid.

135

Chair Ringo

Asks if it is known if people who have special health issues are subject to health problems because of fluoride.

136

Ferre

Remarks that some people say they are allergic to fluoride. Says that fluoride is the thirteenth most common element in the Earth’s crust so it is very hard to avoid.

138

Chair Ringo

Verifies that witness understands what he is asking.

139

Ferre

Replies yes.

140

Chair Ringo

Says that it is one thing to say that it benefits 99 percent of the people in society. Says that he is interested in knowing if there is one percent of people that may have a sensitivity to fluoride that will be adversely affected.

142

Meredith

Replies there is not. Explains how one can become allergic to small molecules.

145

Chair Ringo

Says he does not know how to respond when he gets an email from someone who says they have a liver problem and fluoride presents a special difficulty to them.

150

Meredith

Replies not metabolically and explains.

155

Myers

Asks Chair Ringo to allow the witness from the Center for Disease Control to discuss the issue of purity.

160

William Maas, DDS, MPH

Director, Division of Oral Health; National Center for Chronic Disease Prevention and Health Promotion; Center for Disease Control and Prevention; and U.S. Department of Health and Human Services. Discusses sensitivity to fluoride and the standards of the Environmental Protection Agency (EPA). Discusses the article mentioned earlier published in 2000 regarding the topical effects of fluoride. Discusses the FDA and the EPA and the purity of drinking water. Discusses concerns about whether the water fluoridation decision should be made at the state level or left to local decision making.

266

Chair Ringo

Wonders about adding fluoride for medicinal purposes. Says that it seems medicinal to him because fluoride is being added to the water to provide a health benefit.

271

Maas

Says that it is not the view that the CDC takes. Points out that fluoride occurs naturally in water and they are recommending the level be adjusted to provide optimal health.

280

Chair Ringo

Asks if there is anyone else who is going to testify.

281

Maas

States that Kip Duchon’s testimony is included with his. States that Mr. Duchon is available to answer questions.

290

Chair Ringo

Recesses public hearing on HB 2025 A. Recesses meeting at 3:53 p.m. and the committee stands at ease.

293

Chair Ringo

Calls meeting back to order at 3:58 p.m. and opens work session on SB 740.

SB 740 – WORK SESSION

303

Chair Ringo

Asks Committee Administrator if the -2 amendments are the operative amendments.

304

Matt Shields

Committee Administrator. Replies yes.

308

Chair Ringo

MOTION:  Moves to ADOPT SB 740-2 amendments dated 04/18/05.

VOTE:  5-0-1

EXCUSED:  1 - Burdick

312

Chair Ringo

Hearing no objection, declares the motion CARRIED.

315

Chair Ringo

MOTION:  Moves SB 740 to the floor with a DO PASS AS AMENDED recommendation and BE REFERRED to the committee on Ways and Means by prior reference.

VOTE:  3-2-1

AYE:               3 - President Courtney, Shields, Ringo

NAY:               2 - Atkinson, Beyer

EXCUSED:     1 - Burdick

320

Chair Ringo

The motion CARRIES.

324

Chair Ringo

Closes work session on SB 740 and opens work session on SB 542.

SB 542 – WORK SESSION

342

Chair Ringo

MOTION:  Moves to ADOPT SB 542-1 amendments dated 04/07/05.

VOTE:  5-0-1

EXCUSED:  1 - Burdick

Chair Ringo

Hearing no objection, declares the motion CARRIED.

350

Chair Ringo

MOTION:  Moves SB 542 to the floor with a DO PASS AS AMENDED recommendation and the SUBSEQUENT REFERRAL to the committee on WAYS AND MEANS BE RESCINDED.

360

Chair Ringo

VOTE:  4-1-1

AYE:               4 – Atkinson, President Courtney, Shields, Ringo

NAY:               1 - Beyer

EXCUSED:     1 - Burdick

362

Chair Ringo

The motion CARRIES.

SEN. RINGO will lead discussion on the floor.

363

Chair Ringo

Closes work session on SB 542 and opens work session on SB 659.

SB 659 – WORK SESSION

364

Matt Shields

Committee Administrator. Explains the -1 amendments.

370

Chair Ringo

MOTION:  Moves to ADOPT SB 659-1 amendments dated 04/19/05.

VOTE:  3-2-1

AYE:               3 - President Courtney, Shields, Ringo

NAY:               2 - Atkinson, Beyer

EXCUSED:     1 - Burdick

389

Chair Ringo

The motion CARRIES.

390

Chair Ringo

MOTION:  Moves SB 659 to the floor with a DO PASS AS AMENDED recommendation and BE REFERRED to the committee on Ways and Means.

VOTE:  3-2-1

AYE:               3 - President Courtney, Shields, Ringo

NAY:               2 - Atkinson, Beyer

EXCUSED:     1 - Burdick

393

Chair Ringo

The motion CARRIES.

The following prepared testimony is submitted for the record without prepared testimony:

Michael Carrier

Governor’s Natural Resource Policy Director. Submits written testimony in opposition to SB 659 (EXHIBIT HHH).

395

Chair Ringo

Closes work session on SB 659 and re-opens public hearing on HB 2025 A.

HB 2025 A – PUBLIC HEARING

TAPE 86, B

007

Lynne Campbell

Oregon Citizens for Safe Drinking Water. Hopes that the committee will accept written responses to testimony after today.

010

Chair Ringo

Replies yes. States that both sides of the debate are welcome to submit written material in response.

014

Campbell

Discusses a document from the Food and Drug Administration (FDA) which states that fluoride is a drug regulated by the FDA when ingested for the purpose of reducing tooth decay.

021

Campbell

Urges committee to vote no on HB 2025 A. Shares quotes and information on fluoride in drinking water.

070

Chair Ringo

Asks why this information does not change dentists’ opinions about fluoridation.

073

Campbell

Responds.

077

Chair Ringo

Asks why dentists aren’t persuaded by these arguments.

079

Campbell

Responds.

080

Campbell

Continues sharing information on fluoridation.

136

Chair Ringo

Asks if her written testimony will be provided to the committee.

137

Campbell

Says she will provide copies to the committee. Submits written testimony (EXHIBIT F).

140

Brent Foster

Oregon Chapter Sierra Club & Columbia Riverkeepers. Submits and presents a PowerPoint presentation in opposition to HB 2025 A (EXHIBIT G).

175

Chair Ringo

Asks what other elements on the list might have health impacts.

177

Foster

Replies cadmium.

179

Chair Ringo

Asks if there are any studies showing that cadmium, beryllium, barium or others have adverse health impacts relating to fluoride in water.

181

Foster

States that the medical community has been supportive of fluoride for over fifty years and that there is little incentive to prove this wrong. Discusses level of lead in blood. Discusses levels of arsenic.

207

Foster

Continues presentation (EXHIBIT G).

267

Paul Craig Engelking

Professor of Chemistry, University of Oregon. Submits and highlights written testimony in opposition to HB 2025 A (EXHIBIT H).

355

Chair Ringo

Asks witness to summarize his analysis.

358

Engelking

Summarizes testimony.

394

Chair Ringo

Asks if the Neuhold and Sigler study was done in 1960.

395

Engelking

Replies yes.

396

Chair Ringo

Asks when the Damkaer and Day study was done.

397

Engelking

Replies in the 1980s and explains.

403

Chair Ringo

Discusses age of study.

405

Engelking

Replies that no one has done any other studies.

408

Engelking

Continues summarizing testimony.

The following prepared testimony is submitted for the record without public testimony:

Mel Kohn

State Epidemiologist, Oregon Department of Human Services. Submits written testimony in support of HB 2025 A (EXHIBIT I).

Anne Greenwood

Citizen. Submits written testimony in opposition to HB 2025 A (EXHIBIT J).

Sean Hinckley

Resident, Portland. Submits written testimony in opposition to HB 2025 A (EXHIBIT K).

Jiey Zhang

Resident, Beaverton. Submits written testimony in opposition to HB 2025 A (EXHIBIT L).

Norm Zarr

Resident, Portland. Submits written testimony in opposition to HB 2025 A (EXHIBIT M).

Cascade Anderson Geller

Resident, Portland. Submits written testimony in opposition to HB 2025 A (EXHIBIT N).

Louise Gilman

Resident, Portland. Submits written testimony in opposition to HB 2025 A (EXHIBIT O).

Trina D’Amico

Resident, Hillsboro. Submits written testimony in opposition to HB 2025 A (EXHIBIT P).

Dan Montgomery

Resident, Eugene. Submits written testimony in opposition to HB 2025 A (EXHIBIT Q).

Lisanne Pearcy

Resident, Dallas. Submits written testimony in opposition to HB 2025 A (EXHIBIT R).

David James

Citizen. Submits written testimony in opposition to HB 2025 A (EXHIBIT S).

Kellie Barnes

Resident, Portland. Submits written testimony in opposition to HB 2025 A (EXHIBIT T).

Lauri Tauscher, BSME

Resident, Tigard. Submits written testimony in opposition to HB 2025 A (EXHIBIT U).

Krista Anderson Ross, ND

Resident, West Linn. Submits written testimony in opposition to HB 2025 A (EXHIBIT V).

Cynthia Cournoyer

Citizen. Submits written testimony in opposition to HB 2025 A (EXHIBIT W).

Pauline Reimers

Resident, Portland. Submits written testimony in opposition to HB 2025 A (EXHIBIT X).

Kyra Pauli

Resident, Lake Oswego. Submits written testimony in opposition to HB 2025 A (EXHIBIT Y).

Anne Platt

Resident, Lake Oswego. Submits written testimony in opposition to HB 2025 A (EXHIBIT Z).

Margaret Fancher

Resident, Gresham. Submits written testimony in opposition to HB 2025 A (EXHIBIT AA).

Mary L. Tucker

Resident. Tillamook. Submits written testimony in opposition to HB 2025 A (EXHIBIT BB).

Arlene Stanley

Resident, Oregon City. Submits written testimony in opposition to HB 2025 A (EXHIBIT CC).

Timothy B. Welch, M.D., DDS, FICS

Resident, Eugene. Submits written testimony in support of HB 2025 A (EXHIBIT DD).

John MacArthur

Resident, Bend. Submits written testimony in opposition to HB 2025 A (EXHIBIT EE).

Greg Burke

Resident, Bend. Submits written testimony in opposition to HB 2025 A (EXHIBIT FF).

April Fort

Resident, Portland. Submits written testimony in opposition to HB 2025 A (EXHIBIT GG).

Ann Garrett

Citizen. Submits written testimony in opposition to HB 2025 A (EXHIBIT HH).

Emmylu Lawrence

Citizen. Submits written testimony in opposition to HB 2025 A (EXHIBIT II).

Amber Cook

Resident, Multnomah County. Submits written testimony in opposition to HB 2025 A (EXHIBIT JJ).

Aleksandra Mizgajksa, M.D.

Resident, Lake Oswego. Submits written testimony in opposition to HB 2025 A (EXHIBIT KK).

Anna A. Giedwoyn

Resident, Portland. Submits written testimony in opposition to HB 2025 A (EXHIBIT LL).

Jerzy Giedwoyn, F.D., FACC

Resident, Gresham. Submits written testimony in opposition to HB 2025 A (EXHIBIT MM).

Karen Zeida

Resident, Molalla. Submits written testimony in opposition to HB 2025 A (EXHIBIT NN).

Bridgit Tyler

Resident, Jackson County. Submits written testimony in opposition to HB 2025 A (EXHIBIT OO).

Gaylene Hurley

Resident, Medford. Submits written testimony in opposition to HB 2025 A (EXHIBIT PP).

Jeff and Jennifer Browning

Residents, Bend. Submits written testimony in opposition to HB 2025 A (EXHIBIT QQ).

Doug Vorwaller

Resident, Tigard. Submits written testimony in opposition to HB 2025 A (EXHIBIT RR).

Nancy Rose

Citizen. Submits written testimony in opposition to HB 2025 A (EXHIBIT SS).

Michael Framson

Resident, Medford. Submits written testimony in opposition to HB 2025 A (EXHIBIT TT).

Paul S. Miller, D.O.

Osteopathic Physician and Surgeon. Submits written testimony in opposition to HB 2025 A (EXHIBIT UU).

Scott and Susan Anderson

Residents, Beaverton. Submits written testimony in opposition to HB 2025 A (EXHIBIT VV).

Bill Osmunson, DDS, MPH

Aesthetic Dentistry of Lake Oswego and Director, The Institute for Comprehensive Dental Studies. Submits written testimony in opposition to HB 2025 A (EXHIBIT WW).

Debra Burke

Resident, Bend. Submits signature sheets in support of the Water Quality Assurance Act (EXHIBIT XX).

Lisa Forrest Bogar

Resident, Portland. Submits written testimony in opposition to HB 2025 A (EXHIBIT YY).

Jane Myers

Director of Government Affairs, Oregon Dental Association and Coordinator of Healthy Smiles Coalition. Submits written testimony on behalf of the Oregon Medical Association in support of HB 2025 A (EXHIBIT ZZ). Submits written testimony on behalf of James K. Lace, Oregon Pediatric Society and the Oregon Medical Association, in support of HB 2025 A (EXHIBIT AAA).

April Love, DDS

Tri County Fluoridation Coalition. Submits informational packet in support of HB 2025 A (EXHIBIT BBB).

John A. Walker, M.D.

President, Gastroenterology Consultants P.C. Submits written testimony in opposition to HB 2025 A (EXHIBIT CCC).

Meredith L. Lowry, DO

Citizen. Submits written testimony in opposition to HB 2025 A (EXHIBIT III).

Melissa Powers

Pacific Environmental Advocacy Center. Submits informational packet regarding HB 2025 A (EXHIBIT JJJ).

TAPE 87, B

008

Chair Ringo

Closes public hearing on HB 2025 A. Encourages written testimony to be submitted to the committee. Opens public hearing on HB 2595.

HB 2595 – PUBLIC HEARING

030

Bill Chapman

Sunriver Owners Association. Introduces Mike Brannan.

031

Mike Brannan

Homeowner, Sunriver. Gives background information on Sunriver and the Sunriver Owners Association. Submits written testimony (EXHIBIT DDD).

052

Chair Ringo

States that he thinks HB 2595 makes sense. Believes that the committee will pass HB 2595.

060

Chair Ringo

Closes public hearing and opens work session on HB 2595.

HB 2595 – WORK SESSION

061

Sen. Atkinson

MOTION:  Moves HB 2595 to the floor with a DO PASS recommendation.

VOTE:  3-0-2

EXCUSED:  2 - Burdick, Shields

065

Chair Ringo

Hearing no objection, declares the motion CARRIED.

SEN. WESTLUND will lead discussion on the floor.

068

Chair Ringo

Closes work session on HB 2595 and opens public hearing on SB 1044.

SB 1044 – PUBLIC HEARING

075

Linda Swearingen

Resident, Deschutes County. States that SB 1044 is a housekeeping bill and explains.

087

Chair Ringo

Asks Ms. Swearingen is she has written testimony.

088

Swearingen

Replies no. States that the Association of Oregon Counties is in support of SB 1044.

091

Chair Ringo

Asks position of the Department of Land Conservation and Development (DLCD).

092

Bob Rindy

DLCD. States support for SB 1044. Discusses briefly periodic review. Submits written testimony (EXHIBIT EEE).

095

Chair Ringo

Closes public hearing on SB 1044 and opens work session on SB 1044.

SB 1044 – WORK SESSION

096

Sen. Atkinson

MOTION:  Moves SB 1044 to the floor with a DO PASS recommendation.

VOTE:  3-0-2

EXCUSED:  2 - Burdick, Shields

098

Chair Ringo

Hearing no objection, declares the motion CARRIED.

SEN. ATKINSON will lead discussion on the floor.

101

Chair Ringo

Closes work session on SB 1044 and opens public hearing on HB 2176 A.

HB 2176 A – PUBLIC HEARING

105

Sarah Garrison

Capital Projects Division Manager, Oregon Economic and Community Development Department. Submits written testimony (EXHIBIT FFF). Explains HB 2176 A.

124

Chair Ringo

Asks if the mentioned funds would be available for federal money.

125

Garrison

Replies yes and explains.

129

Chair Ringo

Verifies that the brownfields re-development program would still go forward in Oregon, but there would not be one person coordinating it.

131

Garrison

Replies yes.

132

Chair Ringo

Asks who would be responsible for the brownfields re-development program.

133

Garrison

Replies.

135

Chair Ringo

Closes public hearing on HB 2176 A and opens work session on HB 2176 A.

HB 2176 A – WORK SESSION

140

Sen. Atkinson

MOTION:  Moves HB 2176 A to the floor with a DO PASS recommendation.

VOTE:  3-0-2

EXCUSED:  2 - Burdick, Shields

144

Chair Ringo

Hearing no objection, declares the motion CARRIED.

SEN. ATKINSON will lead discussion on the floor.

145

Chair Ringo

Closes work session on HB 2176 A and opens public hearing on HB 2328 A.

HB 2328 A – PUBLIC HEARING

146

Rep. Phil Barnhart

Represents House District 28. Testifies in support of HB 2328 A.

183

Lana Butterfield

NW Propane Gas Association. Testifies in support of HB 2328 A. Submits informational packet (EXHIBIT GGG).

190

Allen Johnson

Johnson & Sherton, PC. States that he is here to answer questions. Points out that HB 2328 A is a maintenance bill.

195

Chair Ringo

Closes public hearing on HB 2328 A and opens work session on HB 2328 A.

HB 2328 A – WORK SESSION

197

Sen. Atkinson

MOTION:  Moves HB 2328 A to the floor with a DO PASS recommendation.

VOTE:  3-0-2

EXCUSED:  2 - Burdick, Shields

200

Chair Ringo

Hearing no objection, declares the motion CARRIED.

SEN. RINGO will lead discussion on the floor.

202

Chair Ringo

Closes work session on HB 2328 A and adjourns meeting at 4:49 p.m.